alexa Pharmacovigilance-impact-factor|OMICS International| Journal Of Pharmacovigilance

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Pharmacovigilance Impact Factor

According to the website of the Pharmaceutical Information and Pharmacovigilance Association or PIPA. “Pharmacovigilance is the process of (a) monitoring medicines as used in everyday practice to identify previously unrecognised adverse effects or changes in the patterns of adverse effects; (b) assessing the risks and benefits of medicines in order to determine what action, if any, is necessary to improve their safe use; (c) providing information to users to optimise safe and effective use of medicines; (d) monitoring the impact of any action taken”. This definition, wider and more synoptic than many others, imbues Pharmacovigilance with both a wide meaning and an inclusive scope; yet its focus remains on Adverse Drug Reactions (ADRs).
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on October, 2020